Litigation Details for SUCAMPO PHARMA, LLC v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2017)
✉ Email this page to a colleague
SUCAMPO PHARMA, LLC v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-04-13 |
Court | District Court, D. New Jersey | Date Terminated | 2018-07-02 |
Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
Jury Demand | None | Referred To | Lois H. Goodman |
Patents | 6,982,283; 8,026,393; 8,097,653; 8,338,639; 8,389,542 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SUCAMPO PHARMA, LLC v. AMNEAL PHARMACEUTICALS LLC
Details for SUCAMPO PHARMA, LLC v. AMNEAL PHARMACEUTICALS LLC (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-04-13 | 1 | States Patent Nos. 6,982,283, 8,097,653, 8,389,542, 8,026,393, 8,338,639 (collectively, “the patents-in-… Sucampo AG owns United States Patent No. 6,982,283 (“the ’283 patent”) titled “Method For Treating … The ’283 patent was duly and legally issued on January 3, 2006. A copy of the ’283 patent is attached… Sucampo AG owns United States Patent No. 8,097,653 (“the ’653 patent”) titled “Dosage Unit Comprising…The ’653 patent was duly and legally issued on January 17, 2012. A copy of the ’653 patent is attached | External link to document | |
2018-09-19 | 46 | United States Patent Nos. 6,982,283 (“the ‘283 Patent”), 8,026,393 (“the ‘393 Patent”), 8,097,653 …8,097,653 (“the ‘653 Patent”), 8,338,639 (“the ‘639 Patent”), and 8,389,542 (“the ‘542 Patent”) (collectively… This action for patent infringement (the “Patent Litigation”) has been brought by …collectively, the “Sucampo Patents”). Plaintiffs’ commencement of the Patent Litigation was based on its receipt… of patent infringement, Amneal has alleged certain defenses, including that the Sucampo Patents are | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |